Smith & Nephew (SNN) Liabilities and Shareholders Equity (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Liabilities and Shareholders Equity of $10.5 billion for Q4 2025, up 0.99% year-on-year from $10.4 billion in Q4 2024, and down 2.2% on a QoQ basis from $10.7 billion in Q2 2025.
Smith & Nephew (SNN) Liabilities and Shareholders Equity (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $10.5 billion the latest figure, recorded in Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 0.99% year-over-year to $10.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.0 billion (up 100.92% YoY) and the FY2025 annual result came in at $10.5 billion, up 0.99% from the prior year.
- Liabilities and Shareholders Equity retreated to $10.5 billion in Q4 2025 per SNN's latest filing, from $10.7 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for SNN reached as high as $10.7 billion in Q2 2025 and fell as low as $12.0 million in Q4 2022.
- A 5-year average of $6.0 billion and a median of $10.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity tumbled 40.0% — and 2024, when it soared 57422.22%.
- Year by year, Liabilities and Shareholders Equity stood at $20.0 million in 2021, then slumped by 40.0% to $12.0 million in 2022, then jumped by 50.0% to $18.0 million in 2023, then surged by 57422.22% to $10.4 billion in 2024, then grew by 0.99% to $10.5 billion in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $10.5 billion, $10.7 billion, and $10.4 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 10.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.46 Bn |
| Jun 28, 2025 | 10.69 Bn |
| Dec 31, 2024 | 10.35 Bn |
| Jun 29, 2024 | 10.54 Bn |
| Dec 31, 2023 | 18.00 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Dec 31, 2021 | 20.00 Mn |
| Dec 31, 2020 | 9.00 Mn |
| Jun 30, 2020 | 9.54 Bn |
| Dec 31, 2019 | 7.00 Mn |
| Jun 29, 2019 | 8.95 Bn |
| Dec 31, 2018 | 34.00 Mn |
| Jun 30, 2018 | 7.71 Bn |
| Dec 31, 2017 | 21.00 Mn |
| Dec 31, 2016 | 7.34 Bn |
| Dec 31, 2015 | 7.17 Bn |
| Jun 30, 2015 | 7.22 Bn |
| Dec 31, 2014 | 7.31 Bn |
| Sep 30, 2014 | 7.65 Bn |
| Jun 28, 2014 | 7.74 Bn |